Toll-like receptor agonists in cancer therapy

作者：Adams Sylvia^*

来源：Immunotherapy, 2009, 1(6): 949-964.

DOI：10.2217/IMT.09.70

• bacillus Calmette-Guerin
• CpG
• imiquimod
• immunotherapy
• monophosphoryl lipid A
• polyriboinosinic-polyribocytidylic acid
• resiquimod
• Toll-like receptor
• Toll-like receptor agonist
• vaccine adjuvant

Toll-like receptors (TLRs) are pattern-recognition receptors related to the Drosophila Toll protein. TLR activation alerts the immune system to microbial products and initiates innate and adaptive immune responses. The naturally powerful immunostimulatory property of TLR agonists can be exploited for active immunotherapy against cancer. Antitumor activity has been demonstrated in several cancers, and TLR agonists are now undergoing extensive clinical investigation. This review discusses recent advances in the field and highlights potential opportunities for the clinical development of TLR agonists as single agent immunomodulators, vaccine adjuvants and in combination with conventional cancer therapies.

• 出版日期2009-11